Back

Phosphoproteomics of phospholamban R14del heart tissue reveals aberrant regulation of calcium handling and contractility

1 April 2025 (12:10 - 12:20)
Organised by: Logo
Congress Presentation Part of: Genetics: primary arrhythmia syndromes and sudden cardiac death Arrhythmias EHRA Premium Access EHRA 2025 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Doctor Frederik Ernst Deiman

University Medical Centre Groningen, Groningen (Netherlands (The))

5 More presentations in this session

Presentation thumbnail
Polygenic risk scores for risk prediction of atrial fibrillation in cardiac surgery patients: Insights from the prospective, multinational VISION cardiac surgery cohort
Doctor W. McIntyre (Hamilton, CA)
Abstract Slides Video
Presentation thumbnail
Sudden cardiac death in patients with atrial fibrillation: role of heart failure, coronary artery disease and biomarkers - Insights from the ARISTOTLE trial
Doctor B. Kommata (Uppsala, SE)
Abstract Slides Video
Presentation thumbnail
Long-term outcome and therapeutic evolution in Brugada syndrome: A 30-year single-center experience
Doctor C. Monaco (Bordeaux, FR)
Abstract Slides Video
Presentation thumbnail
Impact of genetic variants on ablation outcomes and left ventricular function in left ventricular cardiomyopathy patients undergoing catheter ablation for atrial arrhythmias
Doctor S. Dittrich (Cologne, DE)
Abstract Slides Video
Presentation thumbnail
Unraveling the enigma of DSG2 p.(N266S): a culprit in arrhythmogenic cardiomyopathy
Ms S. Pinci (Padua, IT)
Abstract Slides Video

Access the full session

Session thumbnail
Genetics: primary arrhythmia syndromes and sudden cardiac death
Video

The Event

Event poster

EHRA 2025

1 April 2025 12:10 CET
You may be interested in
thumbnail
Congress Presentation
Phosphoproteomics of PLN R14del heart tissue reveals major myocyte degenerate phenotype, and is attenuated by PLN antisense treatment in vitro
thumbnail
Congress Presentation
Phosphoproteomics distinguishes disease-specific mechanisms for human phospholamban cardiomyopathy reversible by RNA therapy
thumbnail
Congress Session
From bedside to bench and back

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources